Press Releases April 7, 2026 08:00 PM

Medline to report first quarter 2026 results on May 6, 2026

Medline to announce Q1 2026 financial results on May 6 with webcast and conference call

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
MDLN

Medline Inc., a leading provider of medical-surgical products and supply chain solutions, will report its first quarter 2026 financial results on May 6, 2026. The company will host a webcast and conference call to discuss the results and provide supplemental materials before market open.

Medline to report first quarter 2026 results on May 6, 2026
MDLN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Medline is the largest provider of medical-surgical products and supply chain solutions, serving various healthcare points of care worldwide.
  • The company operates globally, employing more than 45,000 people and operating in over 100 countries.
  • Medline is transparent with investors by providing a webcast, conference call, and supplementary materials for Q1 2026 results.

NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results.

Information about Medline’s financial results, including a link to the live webcast, will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website.

About Medline
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs more than 45,000 people worldwide and operates in more than 100 countries. To learn more about how Medline makes healthcare run better, visit www.medline.com.
  
Contacts
Investor Relations:
Karen King
Global Head of Investor Relations

Patrick Flaherty
Director, Investor Relations

(847) 247-7222
[email protected]

Media Relations:
Ben Fox
Vice President, Corporate Communications
(224) 327-9999
[email protected]

Source: Medline Inc.


Risks

  • Financial results could be impacted by fluctuations in healthcare demand and supply chain disruptions, affecting operational performance.
  • Global economic and regulatory changes in healthcare markets may introduce uncertainties in business outcomes.
  • Market reaction risk exists if reported financial results disappoint compared to investor expectations.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026